Atorvastatin versus rosuvastatin: a systematic review and meta-analysis of their effects on inflammatory biomarkers in randomized trials.
Event:
ESC Congress 2025
Topic:
Lipid-Lowering Agents
Session:
Dyslipidaemias: current strategies and innovations
